• Doença Inflamatória intestinal Tópicos de relevância clínica
              (Edição GEDII 2008) Coordenação: Fernando Magro e Francisco Portela [Livro Completo]
  • Inflammatory Bowel Disease a Clinicopathological Approach
              (Edição GEDII 2008) Coordenação: Fernando Magro e Fátima Carneiro [Livro Completo]
  • Terapêutica Farmacológica na Doença Inflamatória Intestinal
              (Edição GEDII 2007) Coordenação: Fernando Magro [Livro Completo]

Cadernos de Formação

  • Cadernos de Formação em Gastrenterologia: Doença de Crohn
              (Edição GEDII 2007) Coordenação: Francisco Portela [Consultar Cadernos de Formação]

Artigos Publicados pelo GEDII

Prospective study of blood viral load of Epstein-Barr virus, herpes virus type 6 and human parvovirus B19 in Crohn's disease: Does therapy matter?
J Clin Virol. 2020

Methylation patterns in dysplasia in inflammatory bowel disease patients.
Scand J Gastroenterol. 2020

Transmural Histological Scoring Systems in Crohn's Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties.
J Crohns Colitis. 2020

Comparison of the Nancy index with continuous Geboes score: histological remission and response in ulcerative colitis.
J Crohns Colitis. 2020

Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020

Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review.
Clin Gastroenterol Hepatol. 2020

Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study.
Inflamm Bowel Dis. 2020

Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.
J Crohns Colitis. 2020

Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab.
Therap Adv Gastroenterol. 2019

Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Surgical Intervention versus Immunomodulatory Therapy.
Digestion. 2019

What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale.
Therap Adv Gastroenterol. 2019

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study.
J Crohns Colitis. 2019

Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years.
Dig Liver Dis. 2019

Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis.
J Crohns Colitis. 2019

Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis.
J Crohns Colitis. 2018

The timing of early therapeutic strategies has a significant impact on Crohn's disease prognosis.
Dig Liver Dis. 2018

Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels.
Gut. 2019

Disagreement Among Gastroenterologists Using the Mayo and Rutgeerts Endoscopic Scores.
Fernandes SR, Pinto JSLD, Marques da Costa P, Correia L; GEDII.
Inflamm Bowel Dis. 2018

A Systematic Review and Meta-Analysis of 6-Thioguanine Nucleotide Levels and Clinical Remission in Inflammatory Bowel Disease.
J Crohns Colitis. 2017

Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation.
EBioMedicine. 2017

Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
J Crohns Colitis. 2017

Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays.
Therap Adv Gastroenterol. 2016

Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
J Crohns Colitis. 2017

Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.
J Crohns Colitis. 2017

Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays.
Aliment Pharmacol Ther. 2016

[Portuguese Consensus on the Diagnosis, Prevention and Treatment of Anaemia in Inflammatory Bowel Disease].
Acta Med Port. 2016

Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.
J Crohns Colitis. 2016

Anaemia in Patients with Inflammatory Bowel Disease - A Nationwide Cross-Sectional Study.
Digestion. 2016

In vitro evaluation of traditionally used Surinamese medicinal plants for their potential anti-leishmanial efficacy.
J Ethnopharmacol. 2016

Assessing overall patient satisfaction in inflammatory bowel disease using structural equation modeling.
Eur J Gastroenterol Hepatol. 2015

Clinical practice in Crohn's disease in bordering regions of two countries: different medical options, distinct surgical events.
J Crohns Colitis. 2010

Ulcerative colitis in northern Portugal and Galicia in Spain.
Inflamm Bowel Dis. 2010

Ulcerative colitis in a Southern European country: a national perspective.
Inflamm Bowel Dis. 2010

Crohn's disease in a southern European country: Montreal classification and clinical activity.
Inflamm Bowel Dis. 2009

Inflammatory bowel disease: a patient's and caregiver's perspective.
Dig Dis Sci. 2009

Abstracts GEDII


Journal of Crohn and Colitis Suplements - Abstracts of the 3rd ECCO Congress
  • A Pharmaco-Epidiemiological approach to estimate IBD prevalence and incidence in Portugal
  • Clinical Characteristics of Portuguese Crown´s Disease patients
  • Natural history of Portuguese Chrohn´s Disease patients
  • Ulcerative Colitis in a South-European Country, a National Perspective

Jornal Português de Gastrenterologia - Vilamoura 4 a 7 de Junho de 2008
  • Estudo Genótipo-Fenótipo em doentes com doença de Crohn
  • Classificação de Montreal em doentes Portugueses com colite ulcerosa
  • Impacto da doença inflamatória intestinal na qualidade de vida – Avaliação Nacional
  • Impacto da doença inflamatória intestinal na qualidade de vida dos cuidadores dos doentes


Jornal Português de Gastrenterologia - XXVII Congresso Nacional de Gastrenterologia e Endoscopia Digestiva
  • A Pharmacoepidemiological approach to estimate the prevalence and incidence of inflammatory bowel disease (ibd) in Portugal
  • Avaliação nacional dos doentes com Doença de Crohn (DC) / Avaliação nacional dos doentes com Colite Ulcerosa (CU)
De 04 de abril a 06 de abril de 2024
Reunião Anual 2024
©2023 GEDII - Grupo de Estudos da Doença Inflamatória Intestinal | Todos os direitos reservados | Links úteis | Termos e condiçoes
Desenvolvido por DogmaSis